Mind + Muscle

technical minds + legal muscle


dig deep

Litigation Strategies – Part II – Bio/Pharma: Innovator Rivalries, Biosimilars, and the Courts (Panel Discussion)

  • 09.15.17
  • 2:45 p.m.

This panel will discuss litigation developments in the biosimilars marketplace of interest to both biologics and biosimilar companies, including recent developments, such as Amgen v. Sandoz.  The panel will also consider implications, as well as litigation strategies and best practices.

Panel Moderator: Uma Everett, Director

Panelist: Stuart Watt, Vice President, Law and Intellectual Property Officer, Amgen

Panelist: J.C. Rozendaal, Director

Panelist: Timothy J. Shea, Jr., Director

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.